Free Sample Reports

5 Results (Page 1 of 1)

UAE Free Sample Markets Research Reports

Healthcare Services

UAE Home Healthcare Market Analysis Sample Report

The UAE home healthcare market was valued at $1.83 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 8.93% from 2022 to 2030 and will reach $3.59 Bn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies, many insurances now include home healthcare. The market is segmented by equipment outlook and by services. Some key players in this market are Omega Home Health Care, Ishraq home healthcare, bayti Home Healthcare, Manzil, Mediclinic, NMC Health, and Alleanza.

LAST UPDATED: Mar, 2024

Pharmaceuticals

Abu Dhabi Oncology Drugs Market Analysis Sample Report

The Abu Dhabi oncology drugs market is projected to grow from $296.3 Mn in 2022 to $635.2 Mn in 2030 with a CAGR of 10% for the year 2022-2030. Geriatric population growth and technological advancements in the treatment of cancer in Abu Dhabi are the major market drivers. AstraZeneca and Pfizer are the key players in the Abu Dhabi oncology drugs market.

LAST UPDATED: Oct, 2023

Healthcare Services

Dubai Home Healthcare Market Analysis Sample Report

The Dubai home healthcare market is projected to grow from $271.06 Mn in 2022 to $362.5 Mn in 2030 with a CAGR of 3.7% for the year 2022-2030. The market is segmented by product, service, and by indication. Aims Healthcare and Manzil Healthcare are the key players in the Dubai home healthcare market.

LAST UPDATED: Oct, 2023

Pharmaceuticals

UAE Oncology Drugs Market Analysis Sample Report

By 2030, it is anticipated that the UAE oncology drugs market will reach a value of $2.54 Bn from $0.98 Bn in 2022, growing at a CAGR of 12.6% during 2022-2030. The oncology drug market in UAE is dominated by a few large pharmaceutical companies such as Biopharma Middle East & Africa, Neopharma Pharmaceutical Plant, and Newbridge Pharmaceuticals FZ LLC. The oncology market in UAE is segmented by different therapeutic areas, into breast cancer, lung cancer, colorectal cancer, prostate cancer, and others. The market is also segmented based on treatment types, such as surgery, radiation therapy, chemotherapy, and targeted therapy.

LAST UPDATED: Aug, 2023

OTC & Nutraceuticals

UAE Nutritional Supplements Market Analysis Sample Report

By 2030, it is anticipated that the UAE nutrition and supplements market will reach a value of $3.94 Bn from $1.91 Bn in 2022, growing at a CAGR of 9.5% during 2022-30. The market is primarily dominated by local players such as Vitabiotics Ltd, Bayer Middle East, and Forever Living Products. The market for nutrition and supplements in the UAE is primarily driven by reimbursement scenarios, increasing consumer awareness for health and lifestyle, and international supplements business. The UAE nutrition and supplements market in UAE is segmented by Type, Product, application, and Distribution Channel.

LAST UPDATED: May, 2023

subscribe to our newsletter
up